Perfil
Wu-Sung Ki es director general y consejero de Celltrion, Inc. En su anterior carrera, el Sr. Ki fue vicepresidente de Celltrion Skincure Co.
Cargos activos de Wu-Sung Ki
| Empresas | Cargo | Inicio |
|---|---|---|
| CELLTRION, INC. | Director Ejecutivo | 20/03/2015 |
Antiguos cargos conocidos de Wu-Sung Ki.
| Empresas | Cargo | Fin |
|---|---|---|
| CELLTRION HEALTHCARE CO., LTD. | Director Ejecutivo | - |
Celltrion Skincure Co., Ltd.
 Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Director/Miembro de la Junta | 15/10/2014 |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CELLTRION, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Celltrion Skincure Co., Ltd.
Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Health Technology |
Celltrion Healthcare Co., Ltd.
 Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
- Bolsa de valores
- Insiders
- Wu-Sung Ki
